Akebia Therapeutics reported $-38570000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Agios Pharmaceuticals AGIO:US USD -89109000 6.24M
Akebia Therapeutics AKBA:US USD -38570000 96.43M
Alnylam Pharmaceuticals ALNY:US USD -247440000 65.85M
Amgen AMGN:US USD 3.5B 62M
Astellas Pharma 4503:JP JPY 108.16B 38.67B
AstraZeneca AZN:LN USD 3.6B 404M
Bayer BAYN:GR EUR 2.45B 2.31B
Biomarin Pharmaceutical BMRN:US USD 27.91M 36.51M
Exelixis EXEL:US USD 88.28M 206K
Fresenius Medical Care FME:GR EUR 771M 27M
GlaxoSmithKline GSK:LN GBP 3.36B 916M
Intercept Pharmaceuticals ICPT:US USD -10064000 808K
Ironwood Pharmaceuticals IRWD:US USD 68.84M 12.82M
Johnson & Johnson JNJ:US USD 7.34B 1.2B
Karyopharm Therapeutics KPTI:US USD -30657000 12.1M
Moderna Inc MRNA:US USD 1.28B 1.24B
Nektar Therapeutics NKTR:US USD -34794000 9.48M
Ptc Therapeutics PTCT:US USD -33710000 29.47M
Regeneron Pharmaceuticals REGN:US USD 1.33B 49.4M
Roche Holding ROG:VX 13.44B 2.56B
Sarepta Therapeutics SRPT:US USD -120652000 80.59M
Seattle Genetics SGEN:US USD -175213000 59.32M